54,291 results on '"Wellcome"'
Search Results
152. Tofacitinib in Depression (TIDE) (TIDE)
153. A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers
154. Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa (IMPROVE)
155. Prevalence Survey of Antimalarial Drug Resistance Markers
156. A Study to Test Three Experimental HIV Vaccines in Healthy Adults. (HIV-CORE 006)
157. Prediction of Recurrent Events With 18F-Fluoride (PREFFIR)
158. The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents
159. Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal Evaluation (SPINDLE)
160. Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.
161. Gonococcal Vaccine Study in Key Populations in Kenya (BexKPK)
162. SUNRISE CRT: Radio Intervention to Stimulate Early Child Development (SUNRISE)
163. Global Syphilis Sequencing
164. Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (WMP-COL)
165. Viability Testing and Transplantation of Marginal Livers (VITTAL)
166. FujiLAM Prospective Evaluation Trial
167. Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) (ITAD)
168. The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
169. Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
170. Evaluation of Patients Who Have Not Had Success With Zidovudine
171. A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
172. The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
173. The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
174. The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS
175. A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past
176. The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
177. The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
178. A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
179. A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
180. Preventing Frequent Sinus Infections in HIV-Infected Patients
181. Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects
182. A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine
183. A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)
184. Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
185. A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
186. A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
187. A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4
188. A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3
189. A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
190. A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
191. Methadone Effects on Zidovudine (ZDV, AZT) Disposition
192. A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection
193. Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
194. A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
195. Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
196. A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons
197. Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
198. A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
199. A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
200. A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.